Personal information
Biography
Graduated in Biochemistry and Neurosciences, C Almeida obtained her Ph.D. in Neurosciences at the Faculty of Medicine of the University of Lisbon. C Almeida's Ph.D. thesis focused on beta-amyloid-dependent synaptic and endosomal dysfunction in Alzheimer's disease was developed in Dr. Gunnar Gouras's laboratory (Weill Cornell Medical College, New York). C Almeida trained in cell biology as an EMBO and Marie Curie fellow in Dr. Daniel Louvard's laboratory (Institute Curie, Paris). She became independent, supported by the Portuguese Science Foundation (FCT) at CEDOC – NOVA Medical school and a Marie Curie Reintegration grant in 2013. She has more than 20 publications on intracellular trafficking mechanisms in healthy and Alzheimer's disease cells with more than 4000 citations (H-index 15). As last author, original research EMBO R 2016, JCS 2021, JBC 2021, 2 BioProtocol 2017, review (Frontiers 2020), invited reviews (CMLS 2018, Curr Op Neurobio 2022), and comment (JCB 2021). Co-author in original research (BioRxiv), invited review (JNeurosci 2018, Traffic 2022), book chapter (2022).
Her main interest is understanding how endolysosomal trafficking is essential for synapse (dys)function. Her team uses advanced cellular systems based on primary mouse and human-induced neurons to analyze endolysosomal and synapse dysfunction with comprehensive, advanced quantitative single-cell and superresolution imaging, biochemical, and neurosciences assays. As PI, C Almeida received four awards (NOVA Blended Learning Award, NOVA/Santander, Maratona da Saude, honorable mention Crioestaminal award) and grants from (iFCT; iNOVA4Health, Marie Curie Integration 2012, Alzheimer’s Association AARG 2017, AA-Rapid Funding 2019, H2020/JPND, H2020 Twinning, FCT PTDC 2018. As mentor, 2 post-doc and 5 PhD fellowships (FCT). She participated in European Twinning project to develop research capacity in lysosomal storage disorders (LYSOCIL, H2020). She has participated in panels committees (Alzheimer's Association, EU-LAC), has editorial roles (Cells, Frontiers), reviews since 2009, for funding agencies (Alzheimer Association (USA); ANR, FRM, France Alzheimer (France), FWO, Belgium Stichting Alzheimer Onderzoek (Belgium), ZonMw (Netherlands); Czech GRIS; Pfizer; iMED, Pepita (Portugal)); 22 journals (including Cell Medicine Reports, EMBO Reports, Molecular Neurodegeneration). Since 2014 coordenates the NMS microscopy facility, and in 2021, CAlmeida was elected for the Scientific Council of NMS and invited to co-Coordinate the NOVA Biomedical research Master.
Activities
Employment (3)
Education and qualifications (3)
Professional activities (8)
Funding (10)
AARG-19-618007-RAPID
CEECIND/00410/2017
Works (50 of 64)
2-s2.0-85158007022
cv-prod-id-2854942
cv-prod-id-2854734
2-s2.0-85101189621
cv-prod-id-2854960
2-s2.0-85117455505
cv-prod-id-2854974
cv-prod-id-2854796
cv-prod-id-2519926
cv-prod-id-2855061
cv-prod-id-2854940
cv-prod-id-2519970
cv-prod-id-1574455
2-s2.0-85084250938
cv-prod-id-2854836
cv-prod-id-1022136
cv-prod-id-1022129
cv-prod-id-4080938
@doctoralThesis{https://hdl.handle.net/1822/56267,}
101561075
cv-prod-id-1022053
cv-prod-id-1022112
cv-prod-id-1019282
201628856
cv-prod-id-1019281
201371383
2-s2.0-79959954909
cv-prod-id-1022023
2-s2.0-34547110577
2-s2.0-34247516510
cv-prod-id-4080936
@doctoralThesis{http://hdl.handle.net/10451/6401,}
cv-prod-id-1021981
cv-prod-id-1021971
2-s2.0-33646461282
cv-prod-id-1021956
2-s2.0-21844448609